Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria
Abstract Metabolic reprogramming (MR) influences progression of chronic myeloid leukaemia (CML) to blast crisis (BC), but metabolic programs may change transiently in a second dimension (metabolic plasticity, MP), driven by environments as hypoxia, affecting cytotoxic potency (CPot) of drugs targeti...
Main Authors: | Luciana S. Salaverry, Tomás Lombardo, María C. Cabral-Lorenzo, Martin L. Gil-Folgar, Estela B. Rey-Roldán, Laura I. Kornblihtt, Guillermo A. Blanco |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-07-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00524-y |
Similar Items
-
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
by: Sun Ramon C, et al.
Published: (2011-11-01) -
Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01) -
Experimental Study on the Recovery of Arsenic and Iron from Arsenic–Iron Precipitate by Carbon Thermal Magnetization Reduction
by: Xuepeng Li, et al.
Published: (2023-02-01) -
Arsenic Trioxide And Thalidomide Combination Induces Autophagy Along With Apoptosis In Acute Myeloid Cell Lines
by: Mahnaz Mohammadi Kian, et al.
Published: (2020-07-01) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01)